Compound file · growth
Batch · 2026-05-22
TZP10mg · lyophilized
Tirzepatide
GLP-1 / GIP dual agonist · 10mg lyophilized
0% HPLC verified· Janoshik
Tirzepatide is a dual GLP-1 and GIP receptor agonist studied for its effects on insulin signaling and metabolic pathway regulation in research models.
Lab ledger
HPLC purity0%
Lab partnerJanoshik Analytical
Batch tested2026-05-22
Certificate of Analysis
View certificate
Price$89.00
Save 12% paying in crypto at checkout
This batch, in trace
99.4%
Batch · 2026-05-22
This compound, this batchJanoshik Analytical · HPLC
Structure
Amino acid
sequence.
39residues
3-letter notation39-residue peptide. Full sequence elided for readability — downloadable on the certificate of analysis.
Modifications
- 01Aib substitutions at positions 2 and 13
- 02C20 fatty diacid sidechain via γ-Glu linker
Notes
Sourcing & handling
Sourcing & manufacturing
Manufactured in a GMP-audited facility (cGMP-compliant)
Storage & reconstitution
Lyophilized: stable at room temperature in original sealed vial. Reconstituted: refrigerate at 2–8°C and use within 28 days. Research use only.
Also in growth